Key Takeaways
- Sector: Consumer, Healthcare Healthtech & Medtech, Media, Technology Software & Gaming.
- Geography: United States.
Analysis
Emil Capital Partners has officially rebranded as ECP Growth, signaling a strategic evolution towards investing in growth-stage companies across the consumer value chain.
This transformation aligns with the successful closing of the firm’s Fund IV, which secured $100 million in committed capital to support its refined investment approach.
Founded in 2011, the firm has built a strong track record of backing early-stage consumer businesses in North America. With this new identity, ECP Growth sharpens its focus on businesses delivering innovative products, technological solutions, and market-responsive offerings.
Fund IV will target companies generating more than $10 million in annual revenue, with investments ranging from $5 million to $20 million. The firm prioritizes businesses with a clear path to profitability within 18 months, especially those enhancing human mobility, offering personalized health and wellness solutions, and optimizing resource efficiency in daily life.
"We’re proud to introduce ECP Growth, which reflects our forward-looking investment strategy," said Marcel Bens, CEO of ECP Growth. "This is a natural next step for our firm as we continue to support companies scaling across the consumer landscape."
ECP Growth maintains a close partnership with the Tengelmann Group, a family-owned investment firm based in Munich with over 150 years of heritage. Christian Haub, Tengelmann’s CEO, voiced support for the rebranding, noting that ECP Growth is now positioned to drive innovation and long-term value creation across a broader spectrum of businesses.
With Fund IV, ECP Growth aims to leverage its deep consumer insight and operational expertise to help founders and entrepreneurs overcome growth-stage challenges and build sustainable, high-impact ventures.